1. |
Khan A, Bilezikian J. Primary hyperparathyroidism:pathophysiology and impact on bone[J]. CMAJ, 2000, 163(2):184-187.
|
2. |
Turken SA, Cafferty M, Silverberg SJ, et al. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism[J]. Am J Med, 1989, 87(5):553-557.
|
3. |
Rubin MR, Bilezikian JP, McMahon DJ, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years[J]. J Clin Endocrinol Metab, 2008, 93(9):3462-3470.
|
4. |
Bilezikian JP, Khan AA, Potts JT Jr, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism:summary statement from the third international workshop[J]. J Clin Endocrinol Metab, 2009, 94(2):335-339.
|
5. |
邢小平, 孔晶, 王鸥.高钙危象的诊治[J].临床内科杂志, 2012, 29(9):590-592.
|
6. |
Calò PG, Pisano G, Tatti A, et al. Intraoperative parathyroid hormone assay during focused parathyroidectomy for primary hyperparathyroidism:is it really mandatory?[J]. Minerva Chir, 2012, 67(4):337-342.
|
7. |
邓先兆, 伍波, 樊友本, 等.原发性甲状旁腺功能亢进的多学科联合诊治120例[J].上海医学, 2012, 35(11):931-934.
|
8. |
苏磊, 王雪晨, 桑剑锋, 等.原发性甲状旁腺功能亢进症合并甲状腺疾病的诊治体会[J].中国普外基础与临床杂志, 2010, 17(12):1290-1293.
|
9. |
贺晓燕, 韩晴, 宁光, 等. 160例原发性甲状旁腺功能亢进症患者临床资料初步分析[J].诊断学理论与实践, 2007, 6(3):243-247.
|
10. |
Kassahun WT, Jonas S. Focus on parathyroid carcinoma[J]. Int J Surg, 2011, 9(1):13-19.
|
11. |
Lee PK, Jarosek SL, Virnig BA, et al. Trends in the incidence and treatment of parathyroid cancer in the United States[J]. Cancer, 2007, 109(9):1736-1741.
|
12. |
Haghighi P, Astariata R, Wepsic T, et al. Concurrent primary parathyroid hyperplasia and parathyroid carcinoma[J]. Arch Pathol Lab Med, 1983, 107(7):349-350.
|
13. |
Boyle NH, Ogg CS, Hartley RB, et al. Parathyroid carcinoma secondary to prolonged hyperplasia in chronic renal failure and in coeliac disease[J]. Eur J SurgOncol, 1999, 25(1):100-103.
|
14. |
Schoretsanitis G, Daskalakis M, Melissas J, et al. Parathyroid carcinoma:clinical presentation and management[J]. Am J Otolaryngol, 2009, 30(4):277-280.
|
15. |
Abdelgadir Adam M, Untch BR, Olson JA Jr. Parathyroid carcin-oma:current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics[J]. Oncologist, 2010, 15(1):61-72.
|
16. |
Marcocci C, Cetani F, Rubin MR, et al. Parathyroid carcinoma[J]. Bone Miner Res, 2008, 23(12):1869-1880.
|
17. |
Uruno T, Kebebew E. How to localize parathyroid tumors in primary thyperparathyroidism?[J]. Endocrinol Invest, 2006, 29(9):840-847.
|
18. |
Hara H, Igarashi A, Yano Y, et al. Ultrasonographic features of parathyroid carcinoma[J]. Endocr J, 2001, 48(2):213-217.
|
19. |
Koea JB, Shaw JH. Parathyroid cancer:biology and management[J]. Surg Oncol, 1999, 8(3):155-165.
|
20. |
Zerizer I, Parsaï A, Win Z, et al. Anatomical and functional localization of ectopic parathyroid adenomas:6-year institutional experience[J]. Nucl Med Commun, 2011, 32(6):496-502.
|
21. |
Hojaij F, Vanderlei F, Plopper C, et al. Parathyroid gland anatomical distribution and relation to anthropometric and demographic parameters:a cadaveric study[J]. Anat Sci Int, 2011, 86(4):204-212.
|
22. |
Bahar G, Feinmesser R, Joshua BZ. et al. Hyperfunctioning intrathyroid parathyroidgland:a potential cause of failure in parath-yroidectomy[J]. Surgery, 2006, 139(6):821-826.
|
23. |
Goodman A, Politz D, Lopez J, et al. Intrathyroid parathyroid adenoma:incidence and location-the case against thyroid lobec tomy[J]. Otolaryngol Head Neck Surg, 2011, 144(6):867-871.
|
24. |
Abboud B, Sleilaty G, Ayoub S, et al. Intrathyroid parathyroid adenoma in primary hyperparathyroidism:can it be predicted preo-peratively[J]. World J Surg, 2007, 31(4):817-823.
|
25. |
Haggi M, Guennadi K, David F, et al. Intrathyroidal parathyroid glands:Small, but mighty (a Napoleonphenomenon)[J]. Surgery, 2012, 152(6):1193-200.
|
26. |
Mazzaglia PJ, Milas M, Berber E, et al. Normalization of 2-week postoperative parathyroid hormone values in patients with primary hyperparathyroidism:four-gland exploration compared to focused-approach surgery[J]. World J Surg, 2010, 34(6):1318-1324.
|
27. |
Stewart ZA, Blackford A, Somervell H, et al. 25-Hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypoc-alcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy[J]. Surgery, 2005, 138(6):1018-1026.
|
28. |
Yen TW, Wilson SD, Krzywda EA, et al. The role of parathyroid hormone measurements after surgery for primary hyperparathyroi-dism[J]. Surgery, 2006, 140(4):665-674.
|
29. |
Beyer TD, Solorzano CC, Prinz RA, et al. Oral vitamin D supp-lementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism[J]. Surgery, 2007, 141(6):777-783.
|
30. |
Robert JH, Trombetti A, Garcia A, et al. Primary hyperparathyroidism:can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature[J]. Ann Surg Oncol, 2005, 12(7):526-532.
|
31. |
朱精强, 刘嘉林, 李霞, 等.原发性甲状旁腺功能亢进症的诊断与治疗(附11例报告)[J].中国普外基础与临床杂志, 1998, 5(5):277-279.
|
32. |
Witteveen JE, van Thiel S, Romijn JA, et al. Hungry bone synd-rome:still a challenge in the postoperative management of primary hyperparathyroidism:a systematic review of the literature[J]. Eur J Endocrinol, 2013, 168(3):R45-R53.
|
33. |
Rubin MR, Bilezikian JP, McMahon DJ, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years[J]. Clin Endocrinol Metab, 2008, 93(9):3462-3470.
|